These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 22528501

  • 1. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.
    Mollica A, Feliciani F, Stefanucci A, Costante R, Lucente G, Pinnen F, Notaristefano D, Spisani S.
    J Pept Sci; 2012 Jun; 18(6):418-26. PubMed ID: 22528501
    [Abstract] [Full Text] [Related]

  • 2. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.
    Pagani Zecchini G, Nalli M, Mollica A, Lucente G, Paglialunga Paradisi M, Spisani S.
    J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519
    [Abstract] [Full Text] [Related]

  • 3. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
    Torino D, Mollica A, Pinnen F, Feliciani F, Spisani S, Lucente G.
    Bioorg Med Chem; 2009 Jan 01; 17(1):251-9. PubMed ID: 19081258
    [Abstract] [Full Text] [Related]

  • 4. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.
    Giordano C, Lucente G, Mollica A, Nalli M, Pagani Zecchini G, Paglialunga Paradisi M, Gavuzzo E, Mazza F, Spisani S.
    J Pept Sci; 2004 Aug 01; 10(8):510-23. PubMed ID: 15347138
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.
    Giordano C, Lucente G, Masi A, Paglialunga Paradisi M, Sansone A, Spisani S.
    Amino Acids; 2007 Sep 01; 33(3):477-87. PubMed ID: 17021652
    [Abstract] [Full Text] [Related]

  • 6. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
    Lucente G, Paradisi MP, Giordano C, Sansone A, Torino D, Spisani S.
    Amino Acids; 2008 Aug 01; 35(2):329-38. PubMed ID: 18163179
    [Abstract] [Full Text] [Related]

  • 7. Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1.
    Witkowska R, Zabrocki J, Spisani S, Falzarano MS, Toniolo C, Formaggio F.
    J Pept Sci; 2003 Jun 01; 9(6):354-60. PubMed ID: 12846481
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.
    Boggian M, Vertuani G, Cavicchioni G, Pecoraro R, Scatturin A, Spisani S.
    Farmaco; 1997 Jun 01; 52(6-7):439-44. PubMed ID: 9372595
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
    Lucente G, Giordano C, Sansone A, Torino D, Spisani S.
    Amino Acids; 2009 Jul 01; 37(2):285-95. PubMed ID: 18636221
    [Abstract] [Full Text] [Related]

  • 10. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
    Cavicchioni G, Breveglieri A, Boggian M, Vertuani G, Reali E, Spisani S.
    J Pept Sci; 1996 Jul 01; 2(3):135-40. PubMed ID: 9231322
    [Abstract] [Full Text] [Related]

  • 11. A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs.
    Cavicchioni G, Spisani S.
    J Pept Res; 2001 Sep 01; 58(3):257-62. PubMed ID: 11576332
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue.
    Torrini I, Paglialunga Paradisi M, Pagani Zecchini G, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S.
    Biopolymers; 1997 Oct 05; 42(4):415-26. PubMed ID: 9283291
    [Abstract] [Full Text] [Related]

  • 13. Beta-peptido sulfonamides: for-Met-Leu-Phe-OMe analogues containing taurine and chiral beta-amino-ethanesulfonic acid residues.
    Giordano C, Nalli M, Paradisi MP, Sansone A, Lucente G, Spisani S.
    Farmaco; 2004 Dec 05; 59(12):953-63. PubMed ID: 15598430
    [Abstract] [Full Text] [Related]

  • 14. Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2.
    Cavicchioni G, Turchetti M, Spisani S.
    J Pept Res; 2002 Oct 05; 60(4):223-31. PubMed ID: 12366529
    [Abstract] [Full Text] [Related]

  • 15. Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position.
    Mollica A, Paglialunga Paradisi M, Torino D, Spisani S, Lucente G.
    Amino Acids; 2006 Jun 05; 30(4):453-9. PubMed ID: 16547648
    [Abstract] [Full Text] [Related]

  • 16. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.
    Pagani Zecchini G, Torrini I, Paglialunga Paradisi M, Lucente G, Spisani S.
    Farmaco; 1994 Nov 05; 40(11):739-42. PubMed ID: 7832975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.
    Cavicchioni G, Fraulini A, Turchetti M, Varani K, Falzarano S, Pavan B, Spisani S.
    Eur J Pharmacol; 2005 Apr 04; 512(1):1-8. PubMed ID: 15814083
    [Abstract] [Full Text] [Related]

  • 19. Fluoro-modified chemotactic peptides: fMLF analogues.
    Koksch B, Dahl C, Radics G, Vocks A, Arnold K, Arnhold J, Sieler J, Burger K.
    J Pept Sci; 2004 Feb 04; 10(2):67-81. PubMed ID: 14994985
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.